{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:22:45Z","timestamp":1758633765201,"version":"3.37.3"},"reference-count":47,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"abstract":"<jats:p>Abstract Subthalamic nucleus deep brain stimulation (STN DBS) is an established treatment that improves motor fluctuations, dyskinesia, and tremor in Parkinson\u2019s disease (PD). After the surgery, a careful electrode programming strategy and medical management are crucial, because an imbalance between them can compromise the quality of life over time. Clinical management is not straightforward and depends on several perioperative motor and non-motor symptoms. In this study, we review the literature data on acute medical management after STN DBS in PD and propose a clinical algorithm on medical management focused on the patient\u2019s phenotypic profile at the perioperative period. Overall, across the trials, the levodopa equivalent daily dose is reduced by 30 to 50% one year after surgery. In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania. On the other hand, a rapid reduction of dopaminergic agonists of more than 70% during the first months can lead to dopaminergic agonist withdrawal syndrome, characterized by apathy, pain, and autonomic features. In a subset of patients with severe dyskinesia before surgery, an initial reduction in levodopa seems to be a more reasonable approach. Finally, when the patient\u2019s phenotype before the surgery is the severe parkinsonism (wearing-off) with or without tremor, reduction of the medication after surgery can be more conservative. Individualized medical management following DBS contributes to the ultimate therapy success.<\/jats:p>","DOI":"10.1590\/0004-282x20190188","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:23:52Z","timestamp":1586633032000},"page":"230-237","source":"Crossref","is-referenced-by-count":2,"title":["Medical management after subthalamic stimulation in Parkinson\u2019s disease: a phenotype perspective"],"prefix":"10.1590","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2150-9300","authenticated-orcid":false,"given":"Ana Paula","family":"BERTHOLO","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8036-2439","authenticated-orcid":false,"given":"Carina","family":"FRAN\u00c7A","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-9526","authenticated-orcid":false,"given":"Wilma Silva","family":"FIORINI","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egberto Reis","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-3327","authenticated-orcid":false,"given":"Rubens Gisbert","family":"CURY","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,4]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","article-title":"Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation","volume":"11","author":"Fasano A","year":"2012","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1474-4422(13)70294-1","article-title":"Mood and behavioural effects of subthalamic stimulation in Parkinson\u2019s disease","volume":"13","author":"Castrioto A","year":"2014","journal-title":"Lancet Neurology"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM200002173420703","article-title":"A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor","volume":"342","author":"Schuurman PR","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1017\/cjn.2016.274","article-title":"Medical Management of Parkinson\u2019s disease after initiation of deep brain stimulation","volume":"43","author":"Fasano A","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/0004-282x20180048","article-title":"Decisions about deep brain stimulation therapy in Parkinson's disease","volume":"76","author":"Brand\u00e3o P","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00415-015-7942-x","article-title":"Referring Parkinson\u2019s disease patients for deep brain stimulation: a RAND\/UCLA appropriateness study","volume":"263","author":"Moro E","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00415-009-0069-1","article-title":"A decision tool to support appropriate referral for deep brain stimulation in Parkinson\u2019s disease","volume":"256","author":"Moro E","year":"2009","journal-title":"J Neurol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1586\/14737175.6.11.1695","article-title":"Criteria for deep-brain stimulation in Parkinson\u2019s disease: review and analysis","volume":"6","author":"Moro E","year":"2006","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneurol.2010.260","article-title":"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues","volume":"68","author":"Bronstein JM","year":"2011","journal-title":"Arch Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/aws078","article-title":"Subthalamic stimulation in Parkinson\u2019s disease: restoring the balance of motivated behaviours","volume":"135","author":"Lhomm\u00e9e E","year":"2012","journal-title":"Brain"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/mds.27101","article-title":"Psychostimulant effect of dopaminergic treatment and addictions in Parkinson\u2019s disease","volume":"32","author":"Delpont B","year":"2017","journal-title":"Mov Disord"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jocn.2008.12.010","article-title":"Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson\u2019s disease","volume":"16","author":"Lim S-Y","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"5854","key":"ref13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.1146157","article-title":"Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism","volume":"318","author":"Frank MJ","year":"2007","journal-title":"Science"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.parkreldis.2015.03.003","article-title":"The medical treatment of patients with Parkinson\u2019s disease receiving subthalamic neurostimulation","volume":"21","author":"Alexoudi A","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"ref15","first-page":"845","article-title":"Assessment of hyper-and hypodopaminergic behaviors in Parkinson\u2019s disease","volume":"165","author":"Ardouin C","year":"2009","journal-title":"Rev Neurol"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp-2012-302387","article-title":"Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson\u2019s disease","volume":"84","author":"Eusebio A","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02509.x","article-title":"Subthalamic deep brain stimulation and impulse control in Parkinson\u2019s disease","volume":"16","author":"H\u00e4lbig TD","year":"2009","journal-title":"Eur J Neurol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0140-17.2017","article-title":"Subthalamic nucleus deep brain stimulation: basic concepts and novel perspectives","volume":"4","author":"Hamani C","year":"2017","journal-title":"eNeuro"},{"issue":"15","key":"ref19","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson CL","year":"2010","journal-title":"Mov Disord"},{"issue":"16","key":"ref20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0000000000000887","article-title":"Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease","volume":"83","author":"Cury RG","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JPD-150712","article-title":"Subthalamic nucleus deep brain stimulation may reduce medication costs in early stage Parkinson\u2019s disease","volume":"6","author":"Hacker ML","year":"2016","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/01.WNL.0000131910.72829.9D","article-title":"L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction","volume":"63","author":"Russmann H","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease","volume":"28","author":"Warren Olanow C","year":"2013","journal-title":"Mov Dis"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1017\/cjn.2016.274","article-title":"Medical management of Parkinson\u2019s Disease after initiation of deep brain stimulation","volume":"43","author":"Fasano A","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5334\/tohm.183","article-title":"Brittle dyskinesia following STN but not GPi deep brain stimulation","volume":"4","author":"Sriram A","year":"2014","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000260077","article-title":"Stimulation-induced dyskinesia in the early stage after subthalamic deep brain stimulation","volume":"88","author":"Zheng Z","year":"2010","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts","volume":"84","author":"Espay AJ","year":"2018","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fneur.2014.00065","article-title":"Surgical treatment of dyskinesia in Parkinson\u2019s disease","volume":"5","author":"Munhoz RP","year":"2014","journal-title":"Front Neurol"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMoa000827","article-title":"Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease","volume":"345","author":"Obeso JA","year":"2001","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1002\/mds.20962","article-title":"Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes","volume":"21","author":"Kleiner-Fisman G","year":"2006","journal-title":"Mov Disord"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.58.3.396","article-title":"Subthalamic DBS replaces levodopa in Parkinson\u2019s disease: two-year follow-up","volume":"58","author":"Vingerhoets FJ","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000342161","article-title":"Microlesion Effect as a Predictor of the Effectiveness of Subthalamic Deep Brain Stimulation for Parkinson\u2019s Disease","volume":"91","author":"Tykocki T","year":"2013","journal-title":"Stereotactic and Functional Neurosurgery"},{"issue":"25","key":"ref33","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1073\/pnas.0610849104","article-title":"Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior","volume":"104","author":"Mallet L","year":"2007","journal-title":"PNAS"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/appi.neuropsych.10070109","article-title":"Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease: a review of the literature","volume":"24","author":"Chopra A","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2006.01.004","article-title":"Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: A systematic review","volume":"12","author":"Temel Y","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/mds.10530","article-title":"Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson\u2019s disease: Manic Episode After STN-DBS","volume":"18","author":"Herzog J","year":"2003","journal-title":"Mov Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2018.04.002","article-title":"Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation","volume":"390","author":"Tareen TK","year":"2018","journal-title":"J Neurol Sci"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp-2012-302444","article-title":"Psychostimulant effect of levodopa: reversing sensitisation is possible","volume":"84","author":"Castrioto A","year":"2013","journal-title":"J J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mds.26223","article-title":"International validation of a behavioral scale in Parkinson\u2019s disease without dementia","volume":"30","author":"Rieu I","year":"2015","journal-title":"Mov Disord"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1474-4422(18)30035-8","article-title":"Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson\u2019s disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial","volume":"17","author":"Lhomm\u00e9e E","year":"2018","journal-title":"Lancet Neurol"},{"issue":"15","key":"ref41","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"24","author":"Aarsland D","year":"2009","journal-title":"Mov Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds to dopaminergic stimulation of D2\/D3 receptors with piribedil","volume":"136","author":"Thobois S","year":"2013","journal-title":"Brain"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois S","year":"2010","journal-title":"Brain"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.21949","article-title":"Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom","volume":"23","author":"Czernecki V","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000107943","article-title":"Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus","volume":"58","author":"Zibetti M","year":"2007","journal-title":"Eur Neurol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/mds.27340","article-title":"Medical and surgical management of advanced Parkinson\u2019s disease: Management of Advanced Parkinson\u2019s Disease","volume":"33","author":"Antonini A","year":"2018","journal-title":"Mov Disord"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuroimage.2014.12.002","article-title":"Lead-DBS: a toolbox for deep brain stimulation electrode localizations and visualizations","volume":"107","author":"Horn A","year":"2015","journal-title":"Neuroimage"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v78n4\/1678-4227-anp-0004-282x20190188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T18:00:25Z","timestamp":1611424825000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2020000400230&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["S0004-282X2020000400230"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20190188","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"type":"electronic","value":"1678-4227"},{"type":"print","value":"0004-282X"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}